Demand is shifting to rapid, decentralized and at-home molecular testing, creating opportunities in consumables, multiplex panels, portable PCR, CRISPR diagnostics and Asia-Pacific expansion.Dublin, ...
PCR technology is a molecular diagnostics technology that detects target nucleic acids by amplifying the DNA amount. It has brought marked progress in the life sciences field since its development in ...
Combining GoCollect® sample preparation with Co-Dx PCR technology could bring blood-based molecular testing closer to ...
SALT LAKE CITY, March 2, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
In recent years, quantitative real-time PCR tests have been extensively developed in clinical microbiology laboratories for routine diagnosis of infectious diseases, particularly bacterial diseases.
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...
Across all areas of life sciences research, scientists are increasingly aware of the need for absolute quantification of nucleic acids. To make their analyses actionable, scientists want to directly ...
According to MarketsandMarkets™, the PCR Technologies Market is projected to reach USD 21.43 billion by 2031 from USD 15.55 billion in 2026, at a CAGR of 6.6% during the forecast period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results